Ambit Biosciences Announces Fourth Quarter And Full-Year 2013 Operating Results

Ambit Biosciences , a biopharmaceutical company focused on discovery and development of drugs targeting unmet needs in oncology, autoimmune and inflammatory disease, today announced fourth quarter and full-year operating results for 2013.

http://ift.tt/1eWYeEK